A trial to compare safety and efficacy of Laparoscopic and Robotic approaches for patients undergoing surgery for adrenal gland lesions.

Comparison of clinical outcomes in Laparoscopic versus Robotic adrenalectomy for benign and malignant adrenal diseases: A randomized controlled trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091693

Enrollment

120

Registered

2025-07-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Robotic Adrenalectomy: This study will help us to realize which minimal access approach (robotics or Laparoscopic ) is better for patients to have a better clinical outcome postoperativ

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 years

Exclusion criteria

Exclusion criteria: Age below 18 yrs Refusal to give consent Patients not fit for general anesthesia and surgical positioning History of previous abdominal Surgeries

Design outcomes

Primary

Measure	Time frame
To compare the clinical outcomes (Safety & Efficacy) between robotic and laparoscopic adrenalectomy in benign and malignant adrenal lesions.Timepoint: Safety and efficacy will be assessed at baseline after surgery and at 2 weeks and 6 weeks after surgery	—

Secondary

Measure	Time frame
To compare the ease of doing the procedure by the surgeon between robotic & laparoscopic adrenalectomy.Timepoint: At baseline, just after the surgery;To compare the robotic & laparoscopic adrenalectomy in terms of conversion to open adrenalectomy. Timepoint: baseline just after the surgical procedure	—

Countries

India

Contacts

Public ContactDr Kunal Soni

All India Institute of Medical Sciences, New Delhi

drpmishra28@gmail.com9971085243

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026